7/16/12
Uterine Cancer
Click to edit Master subtitle style
Endometrial cancer
7/16/12
Endometrial Cancer Uterine Cancer
fourth most common cancer in women frequently occurring gynecological cancer in the United State the US the life time risk of developing endometrial Ca is 2.4% in white women & 1.3% in black exposure to estrogen is considered the major risk factor
most In
Cumulative
September - Uterine Cancer Awareness Month
7/16/12
7/16/12
Tamoxifen
an anti-estrogen used in the Rx of breast Ca has weak estrogenic activity on the genital tract 2 X risk of E Ca when used 5 Y
7/16/12
Other Risk factors
risk in women with breast, ovarian
(endometrial type) & colorectal Ca
Diabetes
3X risk
Hypertension Previous Family
pelvic radiation therapy
Hx of endometrial Ca
7/16/12
Pathophysiology
Uterine cancers are endometrioid
Three types
Type 1 majority of cases estrogen related occurs in younger, obese, and perimenopausal women. low grade and endometrioid
7/16/12
Type
10% high
of cases grade and usually serous cell or clear
cell
older women and African American women Type
10%
affects
of cases hereditary and genetic types related to Lynch II syndrome
7/16/12
Sympto ms
Abnormal
vaginal bleeding, spotting, or
discharge
Pain
or difficulty when emptying the
bladder
Pain Pain
during sex in the pelvic area
7/16/12
Assessment and Diagnostic Findings
Pelvic
exam
7/16/12
Ultrasound
7/16/12
Biopsy
7/16/12
Doctor may order one or more tests:
Pap
test
show cancer cells have spread to the cervix
Blood tests show how well the liver and kidneys
Chest x-ray show a tumor in the lung
CT
scan
can show cancer in the uterus, lymph nodes, lungs, or elsewhere.
MRI
7/16/12
Staging
Stage
surface of the inner lining of the uterus. The doctor may call this carcinoma in situ.
0: The abnormal cells are found only on the
Stage
of the uterus to the endometrium. It may have invaded the myometrium.
I: The tumor has grown through the inner lining
Stage
II: The tumor has invaded the cervix. III: The tumor has grown through the uterus to
Stage
reach nearby tissues, such as the vagina or a lymph node.
Medical management
Surger y Hysterectomy
7/16/12
7/16/12
Bilateral
salpingo-oophorectomy
7/16/12
Radiation
therapy
7/16/12
Chemothera py
7/16/12
Hormone therapy
7/16/12
Prognos is
The 5 Y survival rate for endometrial Ca :
Stage Stage Stage Stage
I 75% II 58% III 30% IV 10%
Overall
5 Y survival 70% most Pt present early due to abnormal vaginal bleeding
7/16/12
Thank You
Click to edit Master subtitle By: style April Joy Ursabia
Maricel Barbas